Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior […]
Nuggets and pyrite in Businessweek article on Celltex Read More »
Last year one of the biggest events in the stem cell field was biotech Geron punting its embryonic stem cell (ESC) program. Much consternation followed. Some folks opposed to ESCs happily pronounced ESC research dead. Some folks in favor of ESC thought the world was ending a year early. Others tried to look on the
The stem cell gestalt of Geron Goodbye and the future of ACT Read More »
It’s been another wacky week in the stem cell world ranging from the Zombie to the Magical. Well, at least it’s Friday, right? In the stem cell world a Friday is not that different than any other day as stem cells often require 7-days a week care, but still Fridays are nice. OK, the
TGIF: The good, bad and zombie stem cell headlines for week of June 15 Read More »
The International Cellular Medicine Society (ICMS) has emerged as an important organization related to stem cell regulatory issues. I think that many people do not understand what ICMS is all about and it certainly evokes strong opinions in the stem cell field. If you care about stem cells then you need to know about ICMS
ICMS President Rodriguez interview on adult stem cell regulatory issues Read More »
Long-time television and music personality, Dick Clark, has passed away at age 82 today. Growing up as a kid in the 1970s and 80s, I knew Dick Clark from American Bandstand and $20,000 pyramid, but more than that I knew him for how amazingly young he always looked. I was not a big fan of
Lessons from Dick Clark about aging and stem cells Read More »
I confess. I have stem cells on the brain! Yeah, I probably have a few stem cells left in this old brain of mine, but that’s not what I mean….rather, I mean that I am really curious and excited about how stem cells do their jobs in our brains. More specifically, I wonder about things
Stem cells on the brain Read More »
Often when we dig a little into the science of stem cells, people get turned off by all the strange names of molecules and jargon. However, whether you are a scientist, patient, investor, reporter, etc. there are some aspects of stem cell science that are ‘musts’ to know about. For example, you need to know
Want to understand stem cells? Then you have to know Myc! Read More »
Readers of The Niche have asked me many questions about stem cells for autoimmune disease but the puzzle of why women get these conditions more often than men hasn’t come up before here. For instance, why is MS so much more common in women than men? It’s remained somewhat of a mystery over the years.
For me, this was another week of heavy grant writing but also taking on Google again. How? Over how badly its search engine often performs on stem cell queries. I have a new piece at MedPage Today. It’s focused on the problem of Google Search promoting unproven stem cell clinic websites. Google still prefers stem
Weekly reads: Google, CIRM, young Swedish bone marrow Read More »
A days ago the news came about Mesoblast not getting FDA approval for its MSC product for GvHD. The MSC area has had a rough few years with various clinical trials including for COVID. The “stem cells for heart disease” arena has also had a tough time. Here’s more news along these lines: BioCardia pauses enrollment in PhIII trial
Weekly reads: BioCardia, HeLa suit, illegal bio lab in CA Read More »